Singulex’ Cardiac Troponin Test Predicts Cardiac Risk In Stable Patients

Jul 28 2016

Results of from a new analysis of plasma samples from an old statin trial suggest that Singulex’ high-sensitivity cardiac troponin test can track the cardiovascular risk in stable patients with ischemic heart disease.

Singulex Inc.’s SMC(Single Molecule Counting) cardiac troponin test can successfully track the risk of worsening cardiovascular disease in stable patients with recent acute coronary syndrome, results of a new study show.

Marc Bonaca of Harvard Medical School, and colleagues in the TIMI Study Group at Brigham And Women’s Hospital in Boston...